Related Experiment Video
Updated: Sep 5, 2025

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?
Yasuyo Ohguchi1, Hiroto Ohguchi1
1Division of Disease Epigenetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto 860-0811, Japan.
Abstract:
Epigenetic modifications are crucial for chromatin remodeling and transcriptional regulation. Post-translational modifications of histones are epigenetic processes that are fine-tuned by writer and eraser enzymes, and the disorganization of these enzymes alters the cellular state, resulting in human diseases. The KDM5 family is an enzymatic family that removes di- and tri-methyl groups (me2 and me3) from lysine 4 of histone H3 (H3K4), and its dysregulation has been implicated in cancer. Although H3K4me3 is an active chromatin marker, KDM5 proteins serve as not only transcriptional repressors but also transcriptional activators in a demethylase-dependent or -independent manner in different contexts. Notably, KDM5 proteins regulate the H3K4 methylation cycle required for active transcription. Here, we review the recent findings regarding the mechanisms of transcriptional regulation mediated by KDM5 in various contexts, with a focus on cancer, and further shed light on the potential of targeting KDM5 for cancer therapy.
Insights
The KDM5 enzyme family, involved in epigenetic regulation, plays a dual role in gene transcription and is implicated in cancer development. Targeting KDM5 offers potential for novel cancer therapies by modulating chromatin remodeling.
Area of Science:
- Epigenetics
- Molecular Biology
- Biochemistry
Background:
- Epigenetic modifications, including histone post-translational modifications, are vital for gene expression and cellular function.
- Enzymes like histone methyltransferases and demethylases regulate these modifications, and their dysregulation is linked to human diseases, particularly cancer.
- The KDM5 family of enzymes specifically removes methyl groups from histone H3 lysine 4 (H3K4me2/3), a marker of active chromatin.
Purpose of the Study:
- To review recent findings on the mechanisms of transcriptional regulation by KDM5 proteins.
- To highlight the context-dependent roles of KDM5 as transcriptional repressors and activators.
- To explore the therapeutic potential of targeting KDM5 in cancer treatment.
Main Methods:
- Literature review of recent research on KDM5 family functions.
- Analysis of KDM5-mediated transcriptional regulation in various cellular contexts.
- Examination of KDM5's role in cancer pathogenesis and therapeutic strategies.
Main Results:
- KDM5 proteins regulate the H3K4 methylation cycle, impacting active transcription.
- KDM5 can act as both transcriptional repressors and activators, depending on the cellular context.
- Dysregulation of KDM5 family members is frequently observed in various cancers.
Conclusions:
- KDM5 proteins are key regulators of chromatin states and gene expression with significant implications in cancer.
- Understanding the multifaceted roles of KDM5 is crucial for developing targeted cancer therapies.
- Targeting KDM5 presents a promising avenue for future anti-cancer drug development.
Related Concept Videos
Co-activators and Co-repressors
Master Transcription Regulators
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

